Accelerating NDA filing through faster carcinogenicity assessment
Drug Discovery World
MAY 10, 2023
Until recently, drug carcinogenicity assessment required two different in vivo studies, one of which was typically a two-year lifetime study in rats. Dr Megan MacBride and Dr Caroline Horizny Mitchell , Taconic, examine recent changes to animal testing in drug design. billion and take over 10 years.
52 
Let's personalize your content